Cetin_2025_J.Biochem.Mol.Toxicol_39_e70591

Reference

Title : Design, Synthesis, and Characterization of Novel Substituted 1,2,4-Triazines: Cytotoxic Activity on HepG2 and HT-29 Cell Lines, Enzyme Inhibition, and Molecular Docking Studies - Cetin_2025_J.Biochem.Mol.Toxicol_39_e70591
Author(s) : Cetin A , Oguz E , Wolinska E , Rozbicki P , Branowska D , Turkan F
Ref : J Biochem Mol Toxicol , 39 :e70591 , 2025
Abstract :

1,2,4-Triazines exhibit various pharmacological properties due to their strong biological activities, such as anticancer, anti-inflammatory, antimicrobial, antiviral, and antioxidant, and also occupy an important place in the pharmaceutical field. The tested compounds were synthesized and characterized. 1,2,4-Triazines were evaluated for their inhibitory and cytotoxicity effects on acetylcholinesterase (AChE), glutathione S-transferase (GST), human liver cancer cell line (HepG2), and human colorectal adenocarcinoma cell line (HT-29). 1,2,4-Triazines (3a-c, 5, 6, 10) were found to inhibit these enzymes with IC(50) values ranging from 1.41 to 4.28 microM for AChE and from 1.58 to 4.13 microM for GST. 1,2,4-Triazine compounds were tested in range of 12.5-100 microM concentrations against HepG2 and HT-29 cell lines. Among the 1,2,4-triazines tested, 10 was the most effective substance on HepG2 cells, especially at high doses, while 3b was effective on HT-29. Furthermore, molecular docking results indicated that the 1,2,4-triazines showed strong binding and stability at the active site of enzymes and selected proteins. 1,2,4-Triazines may serve as promising precursors for the design of potent enzyme inhibitors and anticancer agents.

PubMedSearch : Cetin_2025_J.Biochem.Mol.Toxicol_39_e70591
PubMedID: 41196635

Related information

Citations formats

Cetin A, Oguz E, Wolinska E, Rozbicki P, Branowska D, Turkan F (2025)
Design, Synthesis, and Characterization of Novel Substituted 1,2,4-Triazines: Cytotoxic Activity on HepG2 and HT-29 Cell Lines, Enzyme Inhibition, and Molecular Docking Studies
J Biochem Mol Toxicol 39 :e70591

Cetin A, Oguz E, Wolinska E, Rozbicki P, Branowska D, Turkan F (2025)
J Biochem Mol Toxicol 39 :e70591